Rituximab (R) maintenance versus observation after short term chemoimmunotherapy R-Find as first line treatment in elderly patients with advanced follicular lymphoma (FL) : updated results and safety of the maintenance of an Intergruppo Italiano Linfomi (ILL) randomized trial / U. Vitolo, C. Boccomini, M. Ladetto, E. Gamba, I. Alvarez, L. Baldini, A. Chiappella, A. Chiarenza, P. Corradini, A. De Renzo, A. Evangelista, A. Gallamini, A. Guarini, S. Hohaus, A.M. Liberati, B. Mantoan, L. Orsucci, G. Parvis, M. Petrini, A. Pinto, E. Pogliani, S. Pozzi, A. Pulsoni, L. Rigacci, E. Russo, C. Tarella, A. Tucci, F. Zaja, E. Gallo. - In: BLOOD. - ISSN 0006-4971. - 114:11(2009), pp. 1706-1706. ((Intervento presentato al 51. convegno American Society of Hematology. Annual meeting abstract. tenutosi a New Orleans, LA nel 2009.
Rituximab (R) maintenance versus observation after short term chemoimmunotherapy R-Find as first line treatment in elderly patients with advanced follicular lymphoma (FL) : updated results and safety of the maintenance of an Intergruppo Italiano Linfomi (ILL) randomized trial
L. Baldini;P. Corradini;C. Tarella;
2009
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
